deutsch
ScheBo® • Company News
Video from the Focus 2009 meeting
Dr. David Sanders:Stool Tests Help Gastroenterologists
Focusing on results with faecal pancreatic elastase and faecal lactoferrin from clinical studies conducted at the Royal Hallamshire Hospital in Sheffield, Dr David Sanders discusses the clinical value of faecal diagnostic assays
» link to the video
Pharmaceutical International
Ivor Smith:A Decade of UK Success for Schebo Biotech
» link to the article
Nature 452, 230-233 (13 March 2008)
Heather R. Christofk et al.:Pyruvate kinase M2 is a phosphotyrosine-binding protein
» link to the abstract
Nature 452, 230-233 (13 March 2008)
Heather R. Christofk et al.:The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
» link to the abstract
Castle Rauischholzhausen March 7-8, 2008
Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic DiseasesVeterinary Microbiology, Volume 123, Issue 4, 31-Aug-2007, S. 336-345
Schönenbrücher, H. et al.:Detection of central nervous system tissues in meat products: Validation and standardization of a real-time PCR-based detection system
» link to the abstract
Pharmaceutical International
Leeds, John S.; Sanders, David S.:Coeliac disease and pancreatic exocrine insufficiency
» link to the article
Alimentary Pharmacology & Therapeutics, February 2007, Volume 25, Issue 3, S. 265-271
Leeds, John S. et al.:Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?
» link to the article
British Journal of Cancer, 2007, Volume 96, S. 1329-1334
Haug, U. et al.:Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients
» link to the article
European Journal of Gastroenterology & Hepatology, March 2007, 9(3), S.265-276
Kumar, Y. et al.:Tumour M2-pyruvate kinase: a gastrointestinal cancer marker
» link to the article
World Journal of Gastroenterology 2006 November 21; 12 (43)
Tonus, C.; Neupert, G.; Sellinger, M.:Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
» link to the article
ISO-Certification
Succesful ISO Certification of ScheBo® • Biotech AG on 13. July 2006. Here you find the certificate!38th Meeting of the European Pancreatic Club (EPC), Tampere, Finland, June 7-10, 2006
Ewald, N. et al.:Prevalence of diabetis melitus secondary to pancreatic diseases (type 3c)
JPMorgan Chase Corporate Challenge in Frankfurt on 1. June 2006:
ScheBo® • Biotech AG participated with 7 runners13th UEGW (United European Gastroenterology Week), Copenhagen, Denmark, October 15-19, 2005
Ewald, N. et al.: Pyruvate kinase M2 (Tumor M2-PK) as a screening tool for colorectal cancer (CRC)
NCRI Conference, Birmingham, UK, 2.-5. Oktober 2005
McLoughlin, R.M. et al.:Tumour M2-PK, a novel screening tool for colorectal cancer
Pharmaceutical International
Smith, Ivor:Faster Pancreatic Serum Test Devised by ScheBo® • Biotech
» link to the article
Digestive Disease Week (DDW), Chicago, USA, 14.-19. Mai 2005,
Koss, K. et al.:The potential use of fecal dimeric M2 pyruvate kinase (Tumor M2-PK) in screening for colorectal cancer (CRC)
ASCO 41st Annual Meeting, Orlando, Florida, USA, 13.-17. Mai 2005
Klör, H.U. et al.:The tumor metabolic marker Tumor M2-PK in stool: a new biomarker for colorectal cancer
ASCO 41st Annual Meeting, Orlando, Florida, USA, 13.-17. Mai 2005
Thomas, A. et al.:Tumor M2-Pk as predictive factor in primary systematic chemotherapy in breast cancer
» link to the article
Vet Clin Pathol. 2005; 34(1): 49-51
Battersby IA, Peters IR, Day MJ, German AJ, Hall EJ.:Effect of intestinal inflammation on fecal elastase concentration in dogs
» link to the article
Pharmaceutical International
Smith, Ivor:Faster and Easier ScheBo® • Biotech ′Feacal Elastase Test′
» link to the article
Pharmaceutical International
Allcock, Phil:Tumor M2 Pyruvate Kinase (Tumor M2-PK):
A Tumour Metabolic Marker for Gastrointestinal and other Cancers
» link to the article
Clinical Advances in Hematology and Oncology, October 2004
Clinical Symposia Report: Advances in Gastrointestinal Cancer: A Report from the World GI Congress, June 16-19, 2004, Barcelona, Spaincancerconsultants.com, Cancer News Article, 6. Oktober 2004
New Fecal Screening Test Shows Promise in Detecting Colorectal CancerBritish Journal of Cancer, Press Release, 25. August 2004
Enzyme signpost points to better colon cancer testBBC News, 24. August 2004
′Better′ bowel cancer test foundwashingtontimes.com, 24. August 2004
Germans develop new colon cancer testCancer Compass, 30. Juli 2004
Scientists Present A New Colorectal Cancer Test, Tumour M2-PKAbstract from the World Congress on Gastrointestinal Cancer, June 16-19, 2004, Barcelona, Spain
Hardt, P.D., et al:Tumor M2-PK in Stool: A Screening Tool for Colorectal Cancer
A Decade of UK Success for Schebo Biotech
ScheBo® Biotech UK Limited, a leading provider of unique in-vitro diagnostic tests for the healthcare sector, has just celebrated its 10th Anniversary.
more...
more...
A superior alternative for PLT users: Faecal Pancreatic Elastase Test
Pfizer recommends this test in a letter it sent to pharmacists notifying them about the withdrawal of PLT.
more...
more...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
more...
more...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
more...
more...
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
Fecal tumor M2-PK is an appropriately sensitve tool to pre-select those patients requiring colonoscopy for the further diagnostic confirmation or exclusion of colorectal cancer.
more...
more...